Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans
- PMID: 17675407
- PMCID: PMC1964873
- DOI: 10.1073/pnas.0704774104
Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans
Abstract
Here, we report generation and characterization of Disrupted-In-Schizophrenia-1 (DISC1) genetically engineered mice as a potential model for major mental illnesses, such as schizophrenia. DISC1 is a promising genetic risk factor for major mental illnesses. In this transgenic model, a dominant-negative form of DISC1 (DN-DISC1) is expressed under the alphaCaMKII promoter. In vivo MRI of the DN-DISC1 mice detected enlarged lateral ventricles particularly on the left side, suggesting a link to the asymmetrical change in anatomy found in brains of patients with schizophrenia. Furthermore, selective reduction in the immunoreactivity of parvalbumin in the cortex, a marker for an interneuron deficit that may underlie cortical asynchrony, is observed in the DN-DISC1 mice. These results suggest that these transgenic mice may be used as a model for schizophrenia. DN-DISC1 mice also display several behavioral abnormalities, including hyperactivity, disturbance in sensorimotor gating and olfactory-associated behavior, and an anhedonia/depression-like deficit.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Arguello PA, Gogos JA. Neuron. 2006;52:179–196. - PubMed
-
- Steinpresis RE. Behav Brain Res. 1996;74:45–55. - PubMed
-
- Chen J, Lipska BK, Weinberger DR. Biol Psychiatry. 2006;59:1180–1188. - PubMed
-
- Ishizuka K, Paek M, Kamiya A, Sawa A. Biol Psychiatry. 2006;59:1189–1197. - PubMed
-
- Porteous DJ, Thomson P, Brandon NJ, Millar JK. Biol Psychiatry. 2006;60:123–131. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
